Tuesday, March 09, 2021 5:02:06 AM
As I'm sure you know, absence of evidence isn't evidence of absence.
Until the mechanism behind the rather startling incidence of "numbness and tingling" (aka peripheral neuropathy, which may or may not be serious, may or may not be temporary or more durable) with brilacidin is known it would be foolish to discount some dangerous iatrogenicity.
Not many people have ever been treated with brilacidin but it has shown significant toxicity in every controlled study it's been used in, including quite a few Serious Adverse Events.
I don't think it's right to brush that under the carpet.
In particular I love the way that when the entirely false, misleading and frankly dangerous claim that, and I quote:
"[brilacidin] has been in a number of trials and it has shown 0 side effects for over 400 human patients in those trials to date"
is made, there's nothing but crickets from the commentators who claim some knowledge in this field.
Mention the reality that brilacidin is quite a dirty drug with a narrow therapeutic index in those studies that have been performed and there's a pile on.
Which is interesting and worth remembering when we arrive at the post mortem in due course.
"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."
Upton Sinclair
"Nobody ever went broke underestimating the intelligence of the American public."
H. L. Mencken
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM